(Q44448678)

3 December 2017

The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

3 December 2017

0 references

4

Wim Robberecht

1 reference

3 December 2017

Philip Van Damme

1

1 reference

3 December 2017

Maarten Leyssen

series ordinal

2

1 reference

3 December 2017

Geert Callewaert

series ordinal

3

1 reference

3 December 2017

Ludo Van Den Bosch

series ordinal

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

3 December 2017

343

1 reference

3 December 2017

2

1 reference

3 December 2017

81-84

1 reference

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Brain glutamate deficiency in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Selective vulnerability of spinal cord motor neurons to non-NMDA toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

[3H]d-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Motorneurone disease on Guam: possible role of a food neurotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Na(+) entry through AMPA receptors results in voltage-gated k(+) channel blockade in cultured rat spinal cord motoneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Minocycline delays disease onset and mortality in a transgenic model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900314-8

7 January 2021

10.1016/S0304-3940(03)00314-8

Identifiers

DOI

1 reference

3 December 2017

1 reference